Antioxidants as Complementary Medication in Thalassemia | IntechOpen
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines | Scientific Reports
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation | SpringerLink
Sirolimus for Treatment of β-Thalassemia: From Pre-Clinical Studies to the Design of Clinical Trials
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
β-Thalassemia | Genetics in Medicine
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment | Gene Therapy
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Frontiers | New Insights Into Pathophysiology of β-Thalassemia
Full article: Revisiting beta thalassemia intermedia: past, present, and future prospects
2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
PDF) Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm
Safety and efficacy of thalidomide in patients with transfusion-dependent β- thalassemia: a randomized clinical trial | Signal Transduction and Targeted Therapy
Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
Beta Thalassemia: Practice Essentials, Etiology, Epidemiology
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports
Gene Therapy For Beta-Thalassemia: Updated Perspectives | TACG
Non-transfusion-dependent thalassemias | Haematologica
Pathophysiology and treatment of patients with... | F1000Research
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
